53 employees
Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs.
2019
$2.5M
from 4 investors over 4 rounds
Rejuvenate Bio raised $2.5M on April 12, 2021
Investors: VCapital Management
Rejuvenate Bio raised undisclosed on June 1, 2018
Investors: Companion Fund, Digitalis Ventures and KdT Ventures